Vericel Corp Ord (VCEL) — closed signal from May 18, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on August 16, 2026.
Predicted vs. what happened
VCEL price · publication thesis → realized outcomesplit-adjusted
$32.75 – $34.50Entry zone — fair-value band
$34.08Published — price the day we called it
$40.90Target — the price the thesis aimed for
$49.32Peak — highest point inside the window, not a realized return
$44.20Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 35 days.
Peak price
$49.32
peak on July 30, 2026 — not a realized returnPeak gain
+44.7%
peak, from the publication priceWindow close
$44.20
end-of-window price, context onlyDays to target
35
Window
May 18, 2026 – August 16, 2026
The thesis — published May 18, 2026
Predicted growth
+20%
over the measurement windowTarget price
$40.90
the price the thesis aimed forEntry zone
$32.75 – $34.50
the fair-value band we waited forPrice at publication
$34.08
published May 18, 2026Confidence
68%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Vericel raised its outlook and reported stronger sales, which makes the company's growth story more believable. A recent sharp drop in price could reset expectations and create a clearer opportunity, but trading is thin and the stock is risky with a high valuation. Overall, the upside looks sizable but fragile.
Primary drivers
- Guidance raise shows the business is gaining traction
- Stronger sales signal wider adoption of therapies
- Analyst estimate changes help near-term sentiment
- Pullback offers a contained chance for a rebound
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.